Veradermics Statistics
Total Valuation
Veradermics has a market cap or net worth of $5.30 billion. The enterprise value is $4.94 billion.
Important Dates
The next estimated earnings date is Thursday, August 6, 2026, after market close.
| Earnings Date | Aug 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Veradermics has 41.78 million shares outstanding. The number of shares has increased by 746.32% in one year.
| Current Share Class | 41.78M |
| Shares Outstanding | 41.78M |
| Shares Change (YoY) | +746.32% |
| Shares Change (QoQ) | +2,928.18% |
| Owned by Insiders (%) | 8.01% |
| Owned by Institutions (%) | 51.80% |
| Float | 27.21M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 11.41 |
| P/TBV Ratio | 13.65 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 59.12
| Current Ratio | 59.12 |
| Quick Ratio | 58.43 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -22.86% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$4.12M |
| Employee Count | 24 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 98.08 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 74.13 |
| Average Volume (20 Days) | 728,920 |
Short Selling Information
The latest short interest is 2.36 million, so 5.66% of the outstanding shares have been sold short.
| Short Interest | 2.36M |
| Short Previous Month | 2.06M |
| Short % of Shares Out | 5.66% |
| Short % of Float | 8.69% |
| Short Ratio (days to cover) | 3.76 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -89.29M |
| Pretax Income | -84.83M |
| Net Income | -98.80M |
| EBITDA | n/a |
| EBIT | -89.29M |
| Earnings Per Share (EPS) | -$15.84 |
Full Income StatementBalance Sheet
The company has $390.80 million in cash and n/a in debt, giving a net cash position of $390.80 million or $9.35 per share.
| Cash & Cash Equivalents | 390.80M |
| Total Debt | n/a |
| Net Cash | 390.80M |
| Net Cash Per Share | $9.35 |
| Equity (Book Value) | 390.64M |
| Book Value Per Share | 10.46 |
| Working Capital | 390.35M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$79.45 million and capital expenditures -$5,000, giving a free cash flow of -$79.46 million.
| Operating Cash Flow | -79.45M |
| Capital Expenditures | -5,000 |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | -79.46M |
| FCF Per Share | -$1.90 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |